文献速递乳腺外科

乳腺Paget病保乳手术加放疗与乳房切除术后的肿瘤学结局:系统综述与Meta分析

Oncologic outcomes after breast-conserving surgery with radiotherapy versus mastectomy in patients with Paget's disease of the breast: systematic review and meta-analysis.
PubMed 文献 · Br J Surg · 2023-01-01

该系统综述与Meta分析比较乳腺Paget病患者接受保乳手术加放疗与乳房切除术后的总生存和局部复发。结果显示,合并DCIS的Paget病患者保乳手术后总生存优于乳房切除术;合并IDC的患者保乳加放疗后局部复发风险远高于乳房切除术。

要点

  • 合并DCIS的Paget病患者,保乳手术(加或不加放疗)后总生存优于乳房切除术。
  • 合并IDC的Paget病患者,保乳加放疗后局部复发风险远高于乳房切除术,RR为26.8。
  • 合并IDC的Paget病患者,单纯保乳手术后总生存低于乳房切除术,校正HR为1.64。

核心结论

  • 对于合并DCIS的Paget病患者,保乳手术加放疗可能是与乳房切除术相当的替代治疗选择。
  • 对于经选择的合并IDC的Paget病患者,保乳手术加放疗可能是与乳房切除术相当的替代治疗选择。

研究设计与样本

  • 系统综述与Meta分析,纳入2021年5月前的研究。
  • 主要结局为总生存和局部复发,分别分析Paget病合并DCIS和合并IDC。
  • 采用Meta回归校正保乳手术与乳房切除术患者中IDC比例的不均衡。

主要发现

  • Paget病患者保乳加放疗后总生存高于乳房切除术,合并死亡HR为0.68(95%CI 0.45至1.01)。
  • 合并DCIS的Paget病患者保乳加放疗后总生存优于乳房切除术,校正HR为0.14(0.10至0.20);保乳不加放疗后总生存优于乳房切除术,校正HR为0.28(0.22至0.36)。
  • 合并IDC的Paget病患者保乳加放疗后总生存低于乳房切除术,校正HR为0.84(0.57至1.25);保乳不加放疗后总生存低于乳房切除术,校正HR为1.64(1.04至2.58)。
  • 合并IDC的Paget病患者保乳加放疗后局部复发风险高于保乳不加放疗,RR为26.8(1.60至456)vs RR为51.8(6.80至391)。
  • 合并DCIS的Paget病患者保乳加放疗后局部复发风险低于乳房切除术,RR为0.72(0.11至4.50);保乳不加放疗后局部复发风险略高于乳房切除术,RR为1.38(0.09至21.20)。

临床怎么用

  • 作者认为,对于合并DCIS的Paget病患者,保乳手术加放疗可能是与乳房切除术相当的替代治疗选择。
  • 作者认为,对于经选择的合并IDC的Paget病患者,保乳手术加放疗可能是与乳房切除术相当的替代治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The conventional approach to treatment for Paget's disease of the breast has been mastectomy, but there is an increasing trend to consider breast-conserving surgery (BCS) followed by radiotherapy (RT) in these patients. This study aimed to provide an updated systematic review and meta-analysis comparing outcomes after BCS with RT versus mastectomy in the treatment of Paget's disease of the breast. METHODS: Studies before May 2021 were included. Primary outcomes were overall survival and local recurrence. Separate analyses of Paget's disease associated with ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) were undertaken. Meta-regression was used to adjust for imbalance in the proportion of IDC among patients selected to undergo BCS versus mastectomy. RESULTS: Overall survival in patients with Paget's disease who underwent BCS with RT was higher than for those who underwent mastectomy with pooled mortality hazard ratio (HR) of 0.68, (95% per cent c.i. 0.45 to 1.01). Patients with Paget's disease with DCIS had higher overall survival after BCS with or without RT versus mastectomy, with adjusted HR of 0.14 (0.10 to 0.20) and 0.28 (0.22 to 0.36), respectively. For patients with Paget's disease and IDC, overall survival was lower for BCS with or without RT versus mastectomy, with adjusted HR of 0.84 (0.57 to 1.25) and 1.64 (1.04 to 2.58), respectively. In Paget's disease and IDC, local recurrence risk was much higher for BCS with RT, RR 26.8 (1.60 to 456) versus without RT, RR 51.8 (6.80 to 391). In patients with Paget's disease and DCIS, risk of local recurrence versus mastectomy was lower for BCS with RT 0.72 (0.11 to 4.50) but slightly higher for BCS alone 1.38 (0.09 to 21.20). CONCLUSION: BCS with RT may be a comparable treatment alternative to mastectomy for patients with Paget's disease with DCIS, and for selected patients with Paget's disease and IDC.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Goh SSN, Syn NLX, Lim CJE, et al. Oncologic outcomes after breast-conserving surgery with radiotherapy versus mastectomy in patients with Paget's disease of the breast: systematic review and meta-analysis. Br J Surg. 2023. PMID: 37682691. doi:10.1093/bjs/znad199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。